Barth Syndrome Treatment Market is driven by increasing genetic testing
Barth syndrome is a rare genetic disorder that affects skeletal and cardiac muscle. It occurs predominantly in males and is caused by mutations in the TAZ gene that disrupts phosphatidylcholine metabolism.
Barth Syndrome Treatment Market is driven by increasing genetic testing
disclaimer

What's your reaction?

Comments

https://timessquarereporter.com/public/assets/images/user-avatar-s.jpg

0 comment

Write the first comment for this!

Facebook Conversations